CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC ; volume:14 ; number:1 ; day:9 ; month:4 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (9.4.2024), 1-10, 12.2024
- Urheber
-
Geyer, Fabian
Geyer, Maximilian
Reuning, Ute
Klapproth, Sarah
Wolff, Klaus-Dietrich
Nieberler, Markus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-58958-z
- URN
-
urn:nbn:de:101:1-2406241210163.898242539218
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Geyer, Fabian
- Geyer, Maximilian
- Reuning, Ute
- Klapproth, Sarah
- Wolff, Klaus-Dietrich
- Nieberler, Markus
- SpringerLink (Online service)
Ähnliche Objekte (12)
IL1 Pathway in HPV-Negative HNSCC Cells Is an Indicator of Radioresistance After Photon and Carbon Ion Irradiation Without Functional Involvement
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes
Vergleichbare Cisplatinempfindlichkeit bei HPV-positiven und -negativen HNSCC Zelllinien
Radiosensitivierung von HPV-positiven HNSCC-Zelllinien durch Inhibition von PARP1
HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients
MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial–mesenchymal transition in lung adenocarcinoma
Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Significance of the DNA repair protein ATR on the radiation sensitivity of HPV-positive and HPV-negative HNSCC cells
PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes
The role of stem cell transcription factor Oct4 in the radioresistance of head and neck squamous cell carcinoma (HNSCC)
IL1 Pathway in HPV-Negative HNSCC Cells Is an Indicator of Radioresistance After Photon and Carbon Ion Irradiation Without Functional Involvement
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes
Vergleichbare Cisplatinempfindlichkeit bei HPV-positiven und -negativen HNSCC Zelllinien
Radiosensitivierung von HPV-positiven HNSCC-Zelllinien durch Inhibition von PARP1
HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients
MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial–mesenchymal transition in lung adenocarcinoma
Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Significance of the DNA repair protein ATR on the radiation sensitivity of HPV-positive and HPV-negative HNSCC cells
PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes
The role of stem cell transcription factor Oct4 in the radioresistance of head and neck squamous cell carcinoma (HNSCC)
IL1 Pathway in HPV-Negative HNSCC Cells Is an Indicator of Radioresistance After Photon and Carbon Ion Irradiation Without Functional Involvement
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes
Vergleichbare Cisplatinempfindlichkeit bei HPV-positiven und -negativen HNSCC Zelllinien
Radiosensitivierung von HPV-positiven HNSCC-Zelllinien durch Inhibition von PARP1
HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients
MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial–mesenchymal transition in lung adenocarcinoma
Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Significance of the DNA repair protein ATR on the radiation sensitivity of HPV-positive and HPV-negative HNSCC cells
PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes